feed,title,long_url,short_url
Benzinga,Incyte's Ruxolitinib Shows Better Outcomes Regardless Of Organs Affected In GvHD Patients,https://benzinga.com/general/biotech/21/07/21993740/incytes-ruxolitinib-shows-better-outcomes-regardless-of-organs-affected-in-gvhd-patients,https://j.mp/36JFYT3
